Rapmed Pharmaceutical Private Limited
About Rapmed Pharmaceutical Private Limited
Data last updated:
Rapmed Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52310DL2019PTC350775.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pinki and Tripathi Amit Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 112 West Karawal Nagar Delhi, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.06 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4,524 (net margin -0.2%) and EBITDA of -₹4,524 (EBITDA margin -0.2%). Revenue has grown at a compounded annual rate (CAGR) of 83% over three years.
Company details
Contact details
Rapmed Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 112 West Karawal Nagar Delhi, Delhi, India – 110094
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Rapmed Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rapmed Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Rapmed Pharmaceutical Private Limited, buy the company report.
Financials of Rapmed Pharmaceutical Private Limited
FY 2025 filings availableRapmed Pharmaceutical Private Limited reported revenue of ₹22.06 Lakh (up 676% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 83% over three years, including 676% growth in the latest year. EBITDA fell 503% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4,524 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4,524 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.2% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rapmed Pharmaceutical Private Limited, buy the company report.
Board of directors of Rapmed Pharmaceutical Private Limited
Rapmed Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pinki | Director | 30 May 2019 | 7 Years 5 Months | Current |
| Tripathi Amit Kumar | Additional Director | 08 Oct 2025 | 1 Years 0 Months | Current |
Peer comparison
Rapmed Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Krushimahadhan India Private Limited | ₹22.17 Lakh (FY 2025) | 78.0% | Pune, Maharashtra, India | |||
| Bewar-Agritech Crop Producer Company Limited | ₹22.14 Lakh (FY 2025) | 283.0% | Bhongaon, Uttar Pradesh, India | |||
| G K S Rickshaw Private Limited | ₹22.12 Lakh (FY 2025) | Begusarai, Bihar, India | ||||
| Dhanam Metals Private Limited | ₹22.08 Lakh (FY 2024) | 81.0% | Aurangabad, Maharashtra, India | |||
| Multinex India Private Limited | ₹22.08 Lakh (FY 2024) | Sri Ganganagar, Rajasthan, India | ||||
| Rapmed Pharmaceutical Private Limitedthis company | ₹22.06 Lakh (FY 2025) | -₹4,524 | -0.2% | 676.0% | Delhi, India | |
| Unnati Tieup Private Limited | ₹22.05 Lakh (FY 2025) | 830.0% | Delhi, India | |||
| Whitelotus Fashions Private Limited | ₹22.05 Lakh (FY 2025) | 4187.0% | New Delhi, Delhi, India | |||
| Carat Leaf Services Private Limited | ₹22.03 Lakh (FY 2025) | -91.0% | Meerut, Uttar Pradesh, India | |||
| Rich-Cream Dairy Products Private Limited | ₹22.02 Lakh (FY 2025) | Rahata, Maharashtra, India | ||||
| Sat Guru Distributors Pvt Ltd | ₹21.97 Lakh (FY 2024) | -38.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Rapmed Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rapmed Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rapmed Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rapmed Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rapmed Pharmaceutical Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Tripathi Amit Kumar was appointed as Additional Director on 08 Oct 2025.
Frequently asked questions
Rapmed Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 May 2019 (7+ years old) and is registered under CIN U52310DL2019PTC350775.
Rapmed Pharmaceutical has 2 current directors:
- Pinki - Director
- Tripathi Amit Kumar - Additional Director
The latest financial statements of Rapmed Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Rapmed Pharmaceutical is U52310DL2019PTC350775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rapmed Pharmaceutical was incorporated on 30 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rapmed Pharmaceutical by revenue are Krushimahadhan India Private Limited, Bewar-Agritech Crop Producer Company Limited, G K S Rickshaw Private Limited, Dhanam Metals Private Limited, Multinex India Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Tripathi Amit Kumar was appointed as Additional Director on 08 Oct 2025. Krishna Mani Mishr was appointed as Director on 30 May 2019. Pinki was appointed as Director on 30 May 2019.
The registered office of Rapmed Pharmaceutical is at C – 112 West Karawal Nagar Delhi, Delhi, India – 110094.
Rapmed Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Rapmed Pharmaceutical can be reached at its registered office: C – 112 West Karawal Nagar Delhi, Delhi, India – 110094.
Rapmed Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
